Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mallalieu

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Annals of Plastic Surgery|February 11, 2015
An outcomes analysis of 2142 breast reduction proceduresMichele Ann Manahan, Kate J Buretta, David Chang, et al.
Jac-Antimicrobial Resistance|June 5, 2026
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infectionJun Morita, Kazuya Ishiwata, Shogo Matsumoto, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenemNavita L Mallalieu, Siân Lennon, Mei Liu, et al.
Frontiers in Neuroscience|January 11, 2020
Practices and Attitudes That Enhance Music Engagement of Adult Cochlear Implant UsersKate Gfeller, Ruth MacMullen Mallalieu, Aleksander Mansouri, et al.
Clinical and Translational Science|June 8, 2018
Population Pharmacokinetic and Exposure-dizziness Modeling for a Metabotropic Glutamate Receptor Subtype 5 Negative Allosteric Modulator in Major Depressive Disorder PatientsValérie Cosson, Franziska Schaedeli-Stark, Mona Arab-Alameddine, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2026
Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adultsJun Morita, Kazuya Ishiwata, Shogo Matsumoto, et al.
British Journal of Clinical Pharmacology|November 4, 2015
Use of an integrated modelling and simulation approach to develop a simplified peginterferon alfa-2a dosing regimen for children with hepatitis CBarbara J Brennan, Annabelle Lemenuel-Diot, Eric Snoeck, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2026
A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel β-lactamase inhibitor nacubactamJun Morita, Kazuya Ishiwata, Shogo Matsumoto, et al.
Clinical Therapeutics|December 3, 2014
Pharmacokinetics and pharmacodynamics of setrobuvir, an orally administered hepatitis C virus non-nucleoside analogue inhibitorNavita L Mallalieu, Mohamad H Rahimy, Constance A Crowley, et al.
BMJ Open|October 10, 2019
Gendered relationship between HIV stigma and HIV testing among men and women in Mozambique: a cross-sectional study to inform a stigma reduction and male-targeted HIV testing interventionJudy H Ha, Lynn M Van Lith, Elizabeth C Mallalieu, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Annals of Plastic Surgery|February 11, 2015
An outcomes analysis of 2142 breast reduction proceduresMichele Ann Manahan, Kate J Buretta, David Chang, et al.
Jac-Antimicrobial Resistance|June 5, 2026
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infectionJun Morita, Kazuya Ishiwata, Shogo Matsumoto, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenemNavita L Mallalieu, Siân Lennon, Mei Liu, et al.
Frontiers in Neuroscience|January 11, 2020
Practices and Attitudes That Enhance Music Engagement of Adult Cochlear Implant UsersKate Gfeller, Ruth MacMullen Mallalieu, Aleksander Mansouri, et al.
Clinical and Translational Science|June 8, 2018
Population Pharmacokinetic and Exposure-dizziness Modeling for a Metabotropic Glutamate Receptor Subtype 5 Negative Allosteric Modulator in Major Depressive Disorder PatientsValérie Cosson, Franziska Schaedeli-Stark, Mona Arab-Alameddine, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2026
Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adultsJun Morita, Kazuya Ishiwata, Shogo Matsumoto, et al.
British Journal of Clinical Pharmacology|November 4, 2015
Use of an integrated modelling and simulation approach to develop a simplified peginterferon alfa-2a dosing regimen for children with hepatitis CBarbara J Brennan, Annabelle Lemenuel-Diot, Eric Snoeck, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2026
A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel β-lactamase inhibitor nacubactamJun Morita, Kazuya Ishiwata, Shogo Matsumoto, et al.
Clinical Therapeutics|December 3, 2014
Pharmacokinetics and pharmacodynamics of setrobuvir, an orally administered hepatitis C virus non-nucleoside analogue inhibitorNavita L Mallalieu, Mohamad H Rahimy, Constance A Crowley, et al.
BMJ Open|October 10, 2019
Gendered relationship between HIV stigma and HIV testing among men and women in Mozambique: a cross-sectional study to inform a stigma reduction and male-targeted HIV testing interventionJudy H Ha, Lynn M Van Lith, Elizabeth C Mallalieu, et al.
Pageof 5